Explore the evolving landscape of the weight loss drug market, where Eli Lilly is making strategic moves to cement its position. Listen as the hosts dissect the performance challenges faced by major companies like Tesla and Home Depot amidst fluctuating consumer confidence and economic conditions. This episode provides a comprehensive analysis for investors looking to make informed decisions in uncertain times.
Here is professional money manager Bill Gunderson.
SPEAKER 03 :
And welcome to the Tuesday. It is 2-25-25 today. This is Bill Gunderson, President of Gunderson Capital Management. I’m here with Barry Kite, our Chartered Financial Analyst. And it looks like the beat goes on with the NASDAQ down again today. Pressure on those AI stocks. The Dow is flat. The S&P is down. And Bitcoin is getting clobbered today. So definitely a risk-off kind of day here so far. We’ve gone through a pretty stiff correction here over the last… Really, it began when Palantir said, hey, this government spending cut is going to hurt us. And it’s kind of been down ever since in that AI sector. S&P down 37 right now, 59.46. The Dow down 15, 43,446. The damages in the NASDAQ, Calvert, down 237 points. It’s clear down to 19,049. It’s down 1.2% today. The Russell 2000 down a little bit. Big move in the bond market today. You’re down 7 basis points to 4.33. Is that a flight to safety? Or is that just some normal type action in the bond market? Pretty big drop in interest rates. And Bitcoin getting taken to the cleaners today. Down 7,514 points. That’s 8% drop in Bitcoin. I’m sure that’s impacting the rest of the market. It’s at 86,888. So welcome to today’s Best Stocks Now show with professional money manager Bill Gunderson, president of Gunderson Capital Management. I’m here with Barry Kite, our chartered financial analyst. We’re going through one of those hiccups, Barry, that come along from time to time in the market. It’s a cycle that you go through where the market gets too excited. It runs things up too quickly. And then you get a very swift kick in the rump kind of a correction. And that’s what’s taking place right now. It’s definitely not moving into a bear market. I would say it’s not even a correction yet. It’s more of a pullback. from some very overheated action. But we’re kind of back to where we began the year. That’s the disappointing part of it all. You know, we had an exciting January. We had a pretty exciting February. And really, as I look back, the pendulum started swinging back the other way. That day that Palantir was down in the last couple hours of the market, reality… Yeah, when the Pentagon budget, they’re talking about cuts of roughly 8%.
SPEAKER 04 :
The trick is where the… Obviously, those cuts can come from different places of the budget, so… What is the read-through eventually to earnings rate? My guess is Palantir probably has a little bit more work than they can handle anyway. Who knows? Maybe it shifts them more to non-government clients because I think you mentioned yesterday what government makes up about 55% of their revenues.
SPEAKER 03 :
And, you know, the other thing is I’ve seen a lot of sell-offs over the years triggered by different things over my 25 years. I’ve never seen one triggered by a leaked memo from the new defense secretary. You know, that’s kind of a strange one. But, you know, the NASDAQ was under pressure again yesterday. And it’s all the big winners. It’s the nuclear stocks. A lot of the stuff we’re in, obviously, the AI stocks. Palantir, the cybersecurity stocks. I just don’t think that it’s all over for those companies and those stocks. But, you know, from time to time you have to go through some pretty rough little dips in the road, and that’s just the nature of the beast over the years. I still think that’s where the growth is. You know, Johnson & Johnson is holding up just fine right now, so is Kimberly-Clark and the others. But they haven’t gone up.
SPEAKER 04 :
Well, you mentioned flight to safety. I mean, you’re looking at the 10-year bond. I mean, touching 4.3% today. And in your note earlier this morning, I know you mentioned Bitcoin being down pretty significantly. I mean, down 7.7%. Risk off. Yeah. It’s a risk-off move for sure. Ten basis points move in the ten years is pretty significant.
SPEAKER 03 :
That’s pretty significant. Things seem to be going well. I don’t see any rough patches. The only thing we had was that consumer sentiment thing on Friday with the University of Michigan.
SPEAKER 04 :
And then we just got consumer confidence that came out right when we started the show. Yeah, what was that? And that one wasn’t great, slumps more than consensus. So it came in at 98.3. It was supposed to be at 103. Wow, that’s pretty big.
SPEAKER 03 :
Well, not that much. One listener commented that maybe we’re getting true numbers now, or we weren’t getting true numbers before. I don’t know. U.S. sides with Russia at the U.N. Okay, so that… You know, that would be good news for the world if we could get peace over there, a ceasefire, and work that whole thing out. I think that’s all kind of moving in the right direction. I listened to the press conference yesterday that Trump had with Emmanuel Macron, who flew into Washington, D.C. He’s pretty anxious about Trump solving it without involving Europe. even though we’re the ones that have basically been paying a lot of money. Now, he claims they’re paying a lot of money, too, that they’ve invested a lot in it. But there seems to be some funny kind of accounting there where we have much more of a direct investment in Ukraine that they do. And Look, they’re all posturing. It’s a big, big, wide negotiation that’s taking place. I don’t think Ukraine has much leverage myself. I think Ukraine’s in a very weak spot to negotiate, and I think it would be in their best interest to make some kind of a deal to stop the carnage. And then, of course, you’ve got the rare earth minerals, which sounds like that in principle Ukraine has agreed to that. So anyways, you’ve got that going on in the background. A lot of noise. Bitcoin breaks below 90,000. I just wonder if there’s not a lot of Bitcoin exchanging hands in that whole area of the world. with all the sanctions and everything between Russia, Ukraine. I mean, there’s a lot of corruption and a lot of under the table, a lot of bribery, whatever the case may be. And I’m sure Bitcoin is a big part of that. And you know my stance on Bitcoin. When I went to the closing bell ceremony of the NASDAQ, And we all had a chance to talk about our prospects for this year. And, of course, my best idea was Palantir, but also Lilly. I mean, Lilly’s now the number one ranked stock in the entire app. at the current moment but to a man i didn’t see any women there to a man every single person there and i’d have to say most of them were younger than me uh their top idea for the year was bitcoin okay so i don’t know I just don’t really trust it. I really don’t. And I know Trump is kind of a positive on it and Elon and the others and they’ve got the Bitcoin, the crypto czar and all this and that. I don’t think it’s a good road to be headed down myself. And I only have a tiny little bit, one little ETF in my trading incubator portfolio. But I know some of these people that I was talking to back there on the NASDAQ, they’ve got up to 20%, Barry, of their clients’ money. They feel that it’s an asset class asset. that you have to have exposure to, you know, as a certified financial planner, that it should be part of your asset allocation. I totally disagree with that.
SPEAKER 04 :
Well, and I mean, you know, the whole thing is, you know, you talk about all the time, position size is important, and 20%, right? I mean, you know, I wouldn’t suggest clients have 20%, you know, gold in their portfolio, let alone Bitcoin, right? So, you know, keeping in that… You know, five to, if you’re big on it, right to 10%. That’s what I’m thinking. Five percent.
SPEAKER 01 :
Five. Yeah. Max.
SPEAKER 04 :
Max. Which is what you do, right, in a portfolio when we’re, you know, most of our portfolios are going to have between 20 and 25 names in there. And your position size is usually four to five percent. So, you know, you don’t want to have all your eggs in one basket. And 20%, I mean, just 20% to alternatives in general because it would be in that bucket. In my opinion, it’s one of the problems with some of those large firms is because they tend to put too much towards quote-unquote alternatives.
SPEAKER 03 :
Well, they make the argument, and I don’t agree with this, and I said it in my newsletter on Friday, that alternatives are not non-correlated to the market. Today’s a perfect example. Hmm. When you get a risk-off move in the market, are you trying to tell me that Bitcoin is non-correlated? Heck no. It’s totally correlated to the market. Maybe, you know, not exactly to the economy and everything, but the mood of the market, it’s totally correlated to the market. There’s very few things that are non-correlated. We’ll be right back. And welcome back to the second quarter of today’s Best Docs Now show. You know, you were back there not too long ago in New York with the invitation of ProShares. And ProShares has a double short. Which is fairly new. I put it in my app when they came out with it. It’s been out since not a long time, but they got approved back in March of last year. So it’s been out about nine months. ProShares Ultra Short Bitcoin.
SPEAKER 04 :
I will say the other side of that trade is just as scary as the long side of that trade. It’s up 16.7% today on two times normal volume. There’s also a one-time…
SPEAKER 03 :
Inverse Bitcoin, IBIT. No, let’s see. BITI, B-I-T-I.
SPEAKER 04 :
Yeah, B-I-T-I.
SPEAKER 03 :
B-I-T-I is up 8.4. That’s a pretty good chart. That’s a breakout on BITI today.
SPEAKER 04 :
And then the long version of that one, I think, is B-I-T-B, if I’m not mistaken.
SPEAKER 03 :
If you’ve got a big position in Bitcoin, which I wouldn’t recommend, You can hedge your position with these ProShares inverse Bitcoin ETFs. As far as I know, they’re the only ones. that have a product like that. Okay, a lot of talk about NVIDIA, obviously, leading into tomorrow, tomorrow’s close. Cisco is planning to expand a partnership with NVIDIA. Well, that can only help Cisco to provide AI technology solutions to enterprises. The problem with Cisco has become so big. it’s very hard to get any growth out of it. But I will say the stock has held up pretty well. I see Cisco more these days as a value stock. It has a P.E. ratio of 18. Its dividend yield is clear up to 2.6%. It’s holding up well in this tech sell-off, which I would say is pretty much centered around artificial intelligence, A.I., The valuations got up there pretty rich there, and now they’re starting to correct.
SPEAKER 04 :
And in the software space, it looks like on the AI side, on the software, and then on the energy side, it’s interesting how NVIDIA, and you’ve pointed it out, how NVIDIA’s kind of been a bit of, you know, steadied during this period.
SPEAKER 03 :
It’s held up okay.
SPEAKER 04 :
Even with everything else kind of seemingly falling apart around it, so.
SPEAKER 03 :
Yeah, I would expect a pretty strong report from them. I mean, you can never tell. But I know that there’s a lot of spending taking place, and even ByteDance and the one out of China, what’s the name of the new DeepSeek? They need a lot of NVIDIA chips to run all of that, okay? Yeah. So it’s not like DeepSeek saved a bunch of money, maybe some, but they still are buying the chips like crazy from NVIDIA. So we’ll see. So anyway, Cisco’s trying to get in on the act a little bit here. We’ve had some earnings today. We’ll get to Home Depot. Home Depot is not the same stock as it once was. It’s having a pretty good day today, but it hasn’t done much. Here’s a new one. I’ve got a note to put this in the app after the show here today. D-O-M-H. What the heck does D-O-M-H do? Well, I can tell you why it’s getting a lot of attention today. President Donald Trump’s sons, Donald and Eric, have become investors in the company. DOMH is up 8.6% today. It’s got a pretty good chart. I mean, this thing all of a sudden has just kind of exploded to the upside, and now I know why. Headquartered in New York City, it’s almost like private equity a little bit. They’re engaged in wealth management, investment banking, sales and trading, and asset management. And I went to their website. They have another thing called Alketo Labs, which is a biotech working on cancer. I don’t know who the principals are behind it. I haven’t had enough time to look into it. But they do what we do. Wealth, trust, estate planning.
SPEAKER 04 :
uh so anyways they called themselves industry leaders yeah it’s interesting when i’m looking on it looks like they have maybe 27 employees so yes it’s uh well there’s no sales yeah i mean there’s four million over the last i think they’re allocating capital essentially so we’ll see how we’ll see what it turns up because they’ve got a few of those uh investments as you mentioned
SPEAKER 03 :
Kind of the stock of the day there, D-O-M-H. BWXT, well, it’s alphabet soup today. They outlined $3 billion in 2025 revenue with new acquisitions and robust nuclear demand. Okay, the nuclear stocks are selling off along with the AI. Anything AI seemingly is kind of under pressure. It had a lot of hot money in it, and now you’re seeing some sell-off there. I’m still a big believer in the nuclear renaissance. I mean, is there any reason not to be? It just seems every day we hear about the increasing energy demand, not coming just from AI. But all kinds of different applications. You know, I mean, I just look at my house. I’ve got, you know, I’ve got power strips plugged into power strips, right? I’m surprised more houses don’t catch on fire with all the energy that we use. And so anyways, I just thought I’d bring that up. I did buy a little more. I still like CEG. I still like Constellation Energy. And even though it’s under some pressure, New accounts that have been moving our way. I’ve been buying into the energy, the nuclear renaissance, and I am a big believer in all of it. I’m a believer in these utilities that have big exposure to it, like Constellation, like the one down in Texas. And I’m a big believer in these smaller modular. You know, think about it. When the lights go out, let’s say North Carolina, and you had modular nuclear reactors that a FEMA or the state, whoever ends up being the responder, could roll those in and run the city off of those. There’s just a lot of applications there.
SPEAKER 04 :
It’ll be quieter, so we don’t have to hear generators down the block.
SPEAKER 03 :
They don’t put out nearly what a modular nuclear reactor would. So anyways, even though they’re selling off, I’m still an investor in that space. okay when we come back big news from in in that weight loss space again today in the compounding space uh hims and hers reported earnings today uh lily rolled out new prices uh and uh you know they seem to be rolling on all cylinders right now and out there in indianapolis and i did look at the app today it’s the number one ranked stock in the app overall that’s pretty impressive a big old drug company like Lilly, L-L-Y. We’ll talk about the reason why when we come back. This is the Best Stocks Now show. This is Bill Gunderson. Thank you for tuning in to today’s Best Stocks Now, Best Inverse Funds Now show. I put several hours of research in during the wee hours of the morning each day to bring you the very best cutting-edge stories that I can. To get two free weeks of my newsletter, go to GundersenCapital.com. To talk to us about our fee-based only money management services, call us at 855-611-BEST. Now, back to the second half of the show.
SPEAKER 07 :
Because there’s something in the air. We’ve got to get together sooner or later.
SPEAKER 03 :
And welcome back here to the second half of today’s Best Docs Now show. Eli Lilly announced Tuesday it expanded its weight loss drug offerings, launching new 7.5 milligram and 10 milligram single dose vial formats of its popular weight loss therapy drug, Zepbound, also known as Terzepatide. at $499 per month through its direct-to-consumer website, Lilly Direct. That indicates nearly a 23% discount to the price charged by the Indiana-based drug maker for injector pen versions of the drug at those dose levels. The company also reduced the price of 2.5 mg and 5 mg dose vials of Zepbound launched in August. Those are $3.49 a month for the 2.5 and $4.99 per month for the 5, which was compared to $3.99. So they went down $50 on the 2.5 and they went down $50 on the 5. The latest product offering indicate Lilly’s attempt to establish its dominance in the drug, obesity drug market where its rival Novo Nordisk and compounding operators such as HIMS and HERS also operate. Well, okay, HIMS reported earnings after the close. HIMSS is getting smashed. It’s down 27%. In my opinion, their days are numbered. Find something else.
SPEAKER 04 :
Find the next thing.
SPEAKER 03 :
They were getting around it because there was a shortage. And now the shortage is no longer there. The compounders are charging 230 to 330 for their versions of ZepBound and semaglutide. They faced new restrictions last week after the FDA declared that semaglutide is no longer in shortage. But having said that, they’re turning around and suing the FDA over the semaglutide status. They claim that there still is a shortage. Either way, their days are numbered, okay? They can prolong it, but they’re making copycat versions of Novo Nordisk, a popular weight drug, and they’re making counterfeit versions of Lilly’s. And I would just think that they don’t have much standing there. They don’t have much runway, right? No.
SPEAKER 04 :
I mean, in terms of the, you know, we always talk about, you know, what NVIDIA will be about today in terms of how long, right, will, you know, this increase last going forward for earnings, right? How visible is it going forward? And for HIMSS, it’s not very visible, right?
SPEAKER 03 :
Well, now the other ones are actually making deals with Lilly to be a distributor. Like RO, they’ve made a deal with Lilly so you can go to RO and actually get ZepBound and not the compound. That’s what hims and hers ought to do. I don’t know what their plans are. Now, they’ve had blowout growth. Their sales up 46%, 52%, 77%. And this latest quarter, their sales were up 95% or people are running to get these drugs. which bodes well for Lilly, obviously, because there’s going to come a time when there will only be two, Novo Nordisk and Lilly. The earnings at hims and hers have gone up 200%, 300%, 250%, and this quarter was 11 cents this year versus 1 cent last year, which is 990%. It’s over 1,000%. But, you know, to me, it’s just like you say, they’re running down a runway in this. Okay, Piper Sandler praises NVIDIA ahead of their Q4 results. Their target price, I like looking at these target prices, $175 per share. On NVIDIA, it’s currently $127 per share. There is a little bit of buying coming into NVIDIA. It was down about 3%. Now it’s down about 2.5%. From a technical point of view, it’s holding its 200-day moving average. A break below that would not be very good, in my opinion, from a technical point of view. It’s also kind of got descending tops here over the last couple of months, but it all depends on what they do tomorrow after the close. You can flip a coin, but I lean a little bit towards a really good report tomorrow coming from NVIDIA. So here’s the bottom line. China’s deep seek. Plans for early launch of new AI models. And then they talk about how many NVIDIA chips they’re going to have to buy. They’re scrambling to get the NVIDIA chips so that they can roll this thing out. So this is what Piper Sandler says. They like the setup heading into its earnings call. We sense that our investors are concerned that DeepSeq lowers AI demand. Actually, it doesn’t. It’s increased the demand for these chips. So we’ll see. The demand environment for Blackwell is extremely strong, as evidenced from CapEx raises by the large hyperscaler companies. Do you know that NVIDIA chips are sold out for 2025? And we see increasing cadence of beats of magnitude as the year progresses. So anyways, that’s just one weighing in. And you know that this deep seek has changed the dynamics quite a bit. But not the demand for NVIDIA chips. Tesla sees sharp drop in sales in Europe. Now this is a disturbing trend. the demand for evs and of course they’re uh the number one uh seller of evs in the u.s uh and of course they have a big franchise in europe but you know europe is letting in the chinese cars right i mean they’re letting in byddf and uh lee and neo and some of the others but But listen to this. Year-over-year sales in Europe for Tesla declined 45%. Wow. That’s a huge drop. The chart does not look good at all. Tesla is breaking down. It broke its 50-day moving average. It’s headed for its 200-day moving average. Tesla, I think, probably has a lot to do with the NASDAQ selling off today. Tesla’s down 8% or $27 per share. Maybe Musk has taken his eye off the ball, but I don’t think that’s it.
SPEAKER 04 :
I think it’s just you’ve mentioned it in terms of people just not wanting them anymore. No.
SPEAKER 03 :
I mean, or they’re buying cheaper ones over there in Europe, I suppose. The Tesla is not cheap. And, you know, the tremendous drop in value in the EVs. You know, I told you our sad story about the tremendous, there’s just no demand on the secondary market. There is at a certain price. You’re basically buying the batteries, I suppose. So anyways, that’s not good news for Elon. Cyber attack takes a bite out. Who would attack Krispy Kreme? Who would take to a cyber attack?
SPEAKER 04 :
I saw this, right? I mean, unless you want to get that recipe, I guess that’s it.
SPEAKER 03 :
That’s kind of weird. I mean, you would think there would be deeper pockets. Krispy Kreme is barely a survivor, you know.
SPEAKER 04 :
Hot donuts.
SPEAKER 03 :
They’re buying more GLP-1 drugs than they are chocolate glazed. Okay, chocolate. Not only do they put a layer of glaze on there, then they put a layer of chocolate on top of the glaze. And, you know, you’re going to need two shots of GLP-1.
SPEAKER 04 :
Got that bigger vial now.
SPEAKER 03 :
Now, there is a story out there. I can’t remember. Maybe it was Jeff telling me this. In the biography written on Elon Musk, the guy was in there interviewing him for the book. And Elon says, it’s my lunchtime. And he downed a dozen glazed donuts. He says, that’s kind of a normal lunch for me. And he was also on the GLP-1 drug at the time. So there you go. Elon can be a little bit eccentric at times. You don’t want to get too graphic.
SPEAKER 04 :
You get those hot glazed donuts, I’m telling you.
SPEAKER 03 :
Yeah, 9 o’clock at night. They melt in your mouth.
SPEAKER 04 :
Yeah, you don’t even get to chew.
SPEAKER 03 :
No, they’re good. But Elon’s little boy was, you know, you saw that. Trump needs a new desk now after what his little boy did to it. Home Depot falls after warning the housing market may not improve. Okay. Home Depot is a victim to higher interest rates. Home Depot is up 3.6%, however. It has turned around to the upside, which is good. But when we come back, I want to do a little bit of a dive into Home Depot. It is probably the number one owned stock, along with Johnson & Johnson, in America at the big wire house firms. We’ll be right back.
SPEAKER 1 :
We’ll be right back.
SPEAKER 05 :
And welcome back to the final segment of today’s Best Docs Now show.
SPEAKER 03 :
Well, you know, if you go back 10 years on Home Depot, all right, over the last 10 years, it’s been a pretty good investment. but it’s really slowing down. I mean, it’s really decelerating big time. Over the last 10 years, and you’ll see a pattern here, the stock has delivered an average return of 15.7% per year, which is underneath the S&P 500, which has been 18.4% per year. But as we move forward in time to more current performance, it’s really dropped off. Over the last five years, it’s delivered 12% per year, decelerating from 16% almost over the 10-year period of time. But listen to this. Over the last three years, I think inflation has hurt Home Depot a lot. Look, it’s garden season. It’s spring. Finally. I know it’s not in Minnesota or in Detroit or other markets, Cleveland and whatnot. But we finally, I think, have had our last freeze, knock on wood, here in Charleston. And I’ve got ready to deploy the tomato plants that I started indoors from seed. I buy a pack of seeds. uh and get the varieties i want but you know if you go to home depot i’ll go price one here but last year it’s like seven eight bucks for one tomato plant oh yeah it’s ridiculous i saw a six pack of lettuce plants for like nine dollars i mean i can buy lettuce at the supermarket cheaper than that so i think inflation has hurt home depot a lot and i i I think Amazon has hurt Home Depot a lot because a lot of this stuff delivered to your door. And now I do see, I still get quite a bit from Home Depot, but they deliver to me for free. I guess I’m a blue ribbon customer or whatever. But over the last three years, I mean, this is going to cut into their profits, obviously. An investment in Home Depot, 6% per year average. So it’s decelerated. from fifteen almost sixteen to six and that’s half of what the S&P has done twelve point six and over the last twelve months the stocks up seven point six percent while the S&P is up twenty percent so now you’ve really got a pretty severe under performer okay you’re taking market risk don’t forget you’re taking market risk If the economy goes to heck, Home Depot is not going to do very well. It’s subject to market risk. Now we look, well, Bill, maybe it’s headed down there into the value camp with low P.E. ratios and whatnot. Well, I’m doing the best I can with my valuation, and I come up with about 40% upside potential over the next five years. So you’re taking market risk. Wherein you could buy a five-year bond, Barry, and get the same yield and not have all the volatility and not have that stock market risk.
SPEAKER 04 :
Yeah.
SPEAKER 03 :
So I just don’t, it doesn’t make sense to me. All right. I mean, it goes completely against the grain of what I believe in in the market.
SPEAKER 04 :
Well, when they just beat what, say, I think they finally beat comparable same-store sales, I think, for the first time in a while. I mean, I know they had a streak of not, you know, basically negative same-store sales or comparables, so… I guess I don’t know what the impetus for that is, but you had that boom. Remember the boom during COVID? Everybody was doing stuff in their house, and so you had a lot of this demand pulled forward. Not to mention all of the other issues that you’ve already mentioned in terms of Amazon and other competition, but You know, folks have been project out for a couple years.
SPEAKER 03 :
No, absolutely. So anyways, that’s my story with Home Depot. It’s a very, very popular stock and widely held. Okay, now in the few minutes we have remaining, let’s just look under the hood of the S&P 500. If we want to. Is it clunking along? Is it spitting a little bit of smoke? It’s not like, you know, it’s not like really having a rough day or anything. But the market is definitely going through a pullback right now. And it’s being hit. The winners of this year are being hit the hardest, the AI stocks. Now, okay, so if we go to the S&P 500 and take a look at it, you’re probably going to see Kimberly Clark and Johnson & Johnson doing just fine. Then you’re going to go to the other end of the spectrum. You’re going to see, wow, here’s a surprise, Sempra Energy. I don’t know what’s going on there. That’s the old San Diego Gas and Electric. I’ve written a lot of checks to San Diego Gas and Electric in my lifetime. It’s down 25% today. Check the news on that. Yeah, I’m pulling it up. Tesla also a big loser today, down 6.9%. That’s hurting the NASDAQ, obviously. And I think it’s those Europe numbers, down 48% year over year. What happened to Semprim?
SPEAKER 04 :
Yeah, I mean, well, the first thing I see is missed by a nickel, right? Okay. Okay, so, I mean, that’s not a big miss. Or a big utility. No. Yeah, revenue missed by $970 million. That looks like this revenue looks to be like almost a 25% hit. That’ll be interesting to look at what happened on the revenue side. But they raised their dividend by 4%. And, of course, the stock is down 25% of the money.
SPEAKER 03 :
Yeah, there’s some other news out there somewhere on this. Okay, on the upside today in the S&P, nothing to write home about. Newell Brands, they’re like Rubbermaid, you know, they’re up 5.7. Hanes Brands, underwear up 5%. It’s a good day for the underwear stocks, we’ll put it that way. Domino’s up 3.3%. Pulte Homes up 3.3%. Nothing tech at all. It is totally absent from today’s move. Supermicrocomputer down 9%. And Palantir is down 3.5%. I think the selling is going to abate there pretty soon. That’s still a powerhouse stock, okay? Realty Income, the favorite of our friends at Seeking Alpha, down 3%. yeah you know what that’s just the way we’re going through a little rough patch in the market right now which it happens from time to time it happens about six times a year you just never know when that that’s that’s the trick okay so anyways uh we’re still doing the four-week trial go to gundersoncapital.com we’re still doing financial planning and money management You can set up an appointment with us at 855-611-BEST, 855-611-BEST. And, you know, I try to do a lot of teaching and different things, pulling from my 25 years in the market as a professional money manager with you. Go to our website, GuntersonCapital.com, or call us at 855-611-BEST. Have a great day, everybody.
SPEAKER 02 :
This show is not a solicitation to buy or sell any securities. Bill Gunderson or clients of Gunderson Capital Management may have long or short positions in stocks mentioned during the show. Past performance is not indicative of future performance. Gunderson Capital Management is a fee-based registered investment advisory firm. All accounts are held at Charles Schwab. Schwab is a member of SIBC and FINRA.
